SCHEMBL2004688

SCHEMBL2004688

COc1ccc(Cl)cc1-c1ccc(C(C)NS(=O)(=O)c2ccc(F)c(F)c2)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MEN1 O00255 2/20 0.47
LMNA P02545 2/20 0.47
KMT2A Q03164 2/20 0.47
HTT P42858 2/20 0.47
MAPT P10636 1/20 0.47
THRB P10828 1/20 0.47
PTGS2 P35354 6/20 0.43
PTGS1 P23219 2/20 0.43
PTGES2 Q9H7Z7 1/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TP53 P04637 1/20 0.41
STAT3 P40763 1/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
GHSR Q92847 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004275 0.88 NR3C1 (0.51) ALDH1A1MEN1LMNAKMT2AHTT
SCHEMBL2005613 0.78 NR3C1 (0.62) ALDH1A1MEN1LMNAKMT2AHTT
SCHEMBL2005610 0.78 NR3C1 (0.62) ALDH1A1MEN1LMNAKMT2AHTT
SCHEMBL2002809 0.75 LMNA (0.44) ALDH1A1LMNAHTTPTGS2PTGS1
SCHEMBL1991595 0.70 NR3C1 (0.47) PTGS2PTGS1PTGES2TP53NR3C1
SCHEMBL1989561 0.69 NR3C1 (0.53) LMNAHTTMAPTPTGS2PTGS1
SCHEMBL2007374 0.68 NR3C1 (0.79) NR3C1PGRS1PR1
SCHEMBL5210292 0.67 STAT3 (0.47) ALDH1A1LMNASTAT3PGRS1PR1
SCHEMBL29561916 0.66 ALDH1A1 (0.67) ALDH1A1MEN1LMNAKMT2AHTT
SCHEMBL2100014 0.66 ALDH1A1 (0.50) ALDH1A1MEN1LMNAKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960365-B2 Compounds with medicinal effects due to interaction with the glucocorticoid receptor N.V. ORGANON (NL) 2011-06-14 US disclosed
US-20070149577-A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor N.V. ORGANON (NL) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149577-A1 Compounds with medicinal effects due to interaction with the glucocorticoid receptor NR3C1, NR3C2, MC2R ALDH1A1 1050/4885MEN1 1433/4885LMNA 3879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.